TEVA PHARMACEUTICAL INDUSTRIES LIMITED Cash and Restricted Cash
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) had Cash and Restricted Cash of $3.65 billion as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-07-29
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.65B.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.74B.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.56B.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.20B.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $3.65B 10-Q · filed 2026-07-29 |
| 2026-03-31 | $3.74B 10-Q · filed 2026-07-29 |
| 2025-12-31 | $3.56B 10-Q · filed 2026-07-29 |
| 2025-09-30 | $2.20B 10-Q · filed 2025-11-05 |
| 2025-06-30 | $2.16B 10-Q · filed 2026-07-29 |
| 2025-03-31 | $1.70B 10-Q · filed 2026-07-29 |
| 2024-12-31 | $3.30B 10-Q · filed 2026-07-29 |
| 2024-09-30 | $3.32B 10-Q · filed 2025-11-05 |
| 2024-06-30 | $2.26B 10-Q · filed 2025-11-05 |
| 2024-03-31 | $2.99B 10-Q · filed 2025-07-30 |
| 2023-12-31 | $3.23B 10-K · filed 2026-02-03 |
| 2023-09-30 | $2.25B 10-Q · filed 2024-11-06 |
| 2023-06-30 | $2.67B 10-Q · filed 2024-11-06 |
| 2023-03-31 | $2.18B 10-Q · filed 2024-07-31 |
| 2022-12-31 | $2.83B 10-K · filed 2026-02-03 |
| 2022-09-30 | $2.26B 10-Q · filed 2023-11-09 |
| 2022-06-30 | $2.09B 10-Q · filed 2023-11-09 |
| 2022-03-31 | $2.25B 10-Q · filed 2023-08-02 |
| 2021-12-31 | $2.20B 10-K · filed 2025-02-05 |
| 2021-09-30 | $2.04B 10-Q · filed 2022-11-03 |
| 2021-06-30 | $2.44B 10-Q · filed 2022-07-27 |
| 2021-03-31 | $1.74B 10-Q · filed 2022-05-03 |
| 2020-12-31 | $2.18B 10-K · filed 2024-02-12 |
| 2020-09-30 | $1.83B 10-Q · filed 2021-10-27 |
| 2020-06-30 | $2.40B 10-Q · filed 2021-07-28 |
| 2020-03-31 | $1.80B 10-Q · filed 2021-04-28 |
| 2019-12-31 | $1.98B 10-K · filed 2023-02-10 |
| 2019-09-30 | $1.24B 10-Q · filed 2020-11-05 |
| 2019-06-30 | $2.17B 10-Q · filed 2020-08-05 |
| 2019-03-31 | $1.97B 10-Q · filed 2020-05-07 |
| 2018-12-31 | $1.78B 10-K · filed 2022-02-09 |
| 2018-09-30 | $1.88B 10-Q · filed 2019-11-07 |
| 2018-06-30 | $1.86B 10-Q · filed 2019-08-07 |
| 2018-03-31 | $1.42B 10-Q · filed 2019-05-02 |
| 2017-12-31 | $963.00M 10-K · filed 2021-02-10 |
| 2017-09-30 | $680.00M 10-Q · filed 2018-11-01 |
| 2017-06-30 | $599.00M 10-Q · filed 2018-08-02 |
| 2016-12-31 | $988.00M 10-K · filed 2020-02-21 |
| 2016-01-06 | $6.95B 10-K · filed 2019-02-19 |